91 related articles for article (PubMed ID: 1464019)
1. [Effectiveness of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity].
Poruban D; Koza I; Mracna J; Nagy V; Vasko J
Bratisl Lek Listy; 1992 Aug; 93(8):395-400. PubMed ID: 1464019
[TBL] [Abstract][Full Text] [Related]
2. [Toxicity of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity].
Poruban D; Koza I; Mracna J; Nagy V; Vasko J
Bratisl Lek Listy; 1989 May; 90(5):339-44. PubMed ID: 2758335
[TBL] [Abstract][Full Text] [Related]
3. High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin.
Lin JC; Jan JS; Hsu CY; Wong DY
Cancer; 1999 Apr; 85(7):1430-8. PubMed ID: 10193931
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
[TBL] [Abstract][Full Text] [Related]
5. [The clinical effect of cisplatin and 5-FU infusion in oral cancer].
Okutomi T; Ichihara H; Okuda T; Okumura Y; Hyoudou I; Tatematsu N; Oka N
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1059-62. PubMed ID: 1626942
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
Perrone F; Bossi P; Cortelazzi B; Locati L; Quattrone P; Pierotti MA; Pilotti S; Licitra L
J Clin Oncol; 2010 Feb; 28(5):761-6. PubMed ID: 20048189
[TBL] [Abstract][Full Text] [Related]
7. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.
Kovács AF; Ghahremani MT; Stefenelli U; Bitter K
J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943
[TBL] [Abstract][Full Text] [Related]
8. [Long-term intravenous infusion of 5-fluorouracil combined with platidiam in local spread of squamous cell carcinoma of the oral cavity].
Gorbunova VA; Liubaev VL; Shatikhin VA; Brzhezovskiĭ VZh; Pustynskiĭ IN
Sov Med; 1989; (5):92-4. PubMed ID: 2675338
[No Abstract] [Full Text] [Related]
9. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and 5-fluorouracil as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer.
Wang HM; Wang CH; Chen JS; Chang HK; Kiu MC; Liaw CC; Ng KT; Lai GM
J Formos Med Assoc; 1995 Mar; 94(3):87-94. PubMed ID: 7613250
[TBL] [Abstract][Full Text] [Related]
12. Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU).
Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shigeta T; Shibuya Y; Yokoo S; Komori T
Kobe J Med Sci; 2004; 50(5-6):189-96. PubMed ID: 16107776
[TBL] [Abstract][Full Text] [Related]
13. Intraarterial chemotherapy as neoadjuvant treatment of oral cancer.
Kovács AF; Turowski B; Ghahremani MT; Loitz M
J Craniomaxillofac Surg; 1999 Oct; 27(5):302-7. PubMed ID: 10717833
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center.
Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S
Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with nedaplatin and 5-fluorouracil for oral squamous cell carcinomas].
Yamaoka K; Fukuda M; Kuwajima S; Hagiwara H; Toshima S; Matsuoka A; Ohnuki T; Seki H; Nagai H; Iino M; Sageshima M
Gan To Kagaku Ryoho; 2003 Jul; 30(7):951-5. PubMed ID: 12894709
[TBL] [Abstract][Full Text] [Related]
16. [Low-dose CDDP and 5-FU for head and neck cancer patients].
Fujii M; Kanke M; Tomita T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
Yamshita Y; Shikimori M; Goto M
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1267-71. PubMed ID: 16184922
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity].
Bootz F
HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725
[No Abstract] [Full Text] [Related]
20. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S
BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
